Home » Fitch Reaffirms Bristol-Myers Squibb Ratings
Fitch Reaffirms Bristol-Myers Squibb Ratings
Fitch Ratings affirmed Bristol-Myers Squibb Co.’s ratings and said the outlook for the company remains “Stable,” citing moves by Bristol-Myers to offset the potential loss of future revenue as blockbuster drugs lose patent protection.
Forbes
Forbes
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May